Clinical Trial Update: A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis [Phase 1]

View source ↗

Summary

A Phase 1/1b clinical trial is evaluating the safety, tolerability and pharmacokinetics of ZL-1503 in healthy volunteers and adults with moderate to severe atop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• ZL-1503

Snippet

Sponsor: Zai Lab (Shanghai) Co., Ltd. | Conditions: Atopic Dermatitis (AD) | Phase 1 | Status: RECRUITING